Online inquiry

IVTScrip™ mRNA-Human AP1G2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK16175MR)

This product GTTS-WK16175MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the AP1G2 protein. This product can be used in Mitotic fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001282474.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 8906
UniProt ID O75843
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human AP1G2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK16175MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK27336MR IVTScrip™ mRNA-Human APOL6, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA APOL6
GTTS-WK14128MR IVTScrip™ mRNA-Human ABCA10, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ABCA10
GTTS-WK11146MR IVTScrip™ mRNA-Human ABCC2, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ABCC2
GTTS-WK28182MR IVTScrip™ mRNA-Human ATP1A1, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA ATP1A1
GTTS-WK21488MR IVTScrip™ mRNA-Human ANKHD1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKHD1
GTTS-WK26129MR IVTScrip™ mRNA-Human APOC3, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA APOC3
GTTS-WK20979MR IVTScrip™ mRNA-Human AP2A1, (Cap 1, 2-Thio-UTP, 30 nt-poly(A)) mRNA AP2A1
GTTS-WK26093MR IVTScrip™ mRNA-Human ATP2C2, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ATP2C2
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →